These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 19364291)

  • 1. Dopamine-related genotypes and the dose-response effect of methylphenidate on eating in attention-deficit/hyperactivity disorder youths.
    Leddy JJ; Waxmonsky JG; Salis RJ; Paluch RA; Gnagy EM; Mahaney P; Erbe R; Pelham WE; Epstein LH
    J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):127-36. PubMed ID: 19364291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.
    Froehlich TE; Epstein JN; Nick TG; Melguizo Castro MS; Stein MA; Brinkman WB; Graham AJ; Langberg JM; Kahn RS
    J Am Acad Child Adolesc Psychiatry; 2011 Nov; 50(11):1129-1139.e2. PubMed ID: 22024001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.
    Joober R; Grizenko N; Sengupta S; Amor LB; Schmitz N; Schwartz G; Karama S; Lageix P; Fathalli F; Torkaman-Zehi A; Ter Stepanian M
    Neuropsychopharmacology; 2007 Jun; 32(6):1370-6. PubMed ID: 17063150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder.
    McGough JJ; McCracken JT; Loo SK; Manganiello M; Leung MC; Tietjens JR; Trinh T; Baweja S; Suddath R; Smalley SL; Hellemann G; Sugar CA
    J Am Acad Child Adolesc Psychiatry; 2009 Dec; 48(12):1155-64. PubMed ID: 19858760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine transporter genotype and methylphenidate dose response in children with ADHD.
    Stein MA; Waldman ID; Sarampote CS; Seymour KE; Robb AS; Conlon C; Kim SJ; Cook EH
    Neuropsychopharmacology; 2005 Jul; 30(7):1374-82. PubMed ID: 15827573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial.
    Pasini A; Sinibaldi L; Paloscia C; Douzgou S; Pitzianti MB; Romeo E; Curatolo P; Pizzuti A
    Eur J Paediatr Neurol; 2013 Jul; 17(4):407-14. PubMed ID: 23541676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic and noradrenergic gene polymorphisms and response to methylphenidate in korean children with attention-deficit/hyperactivity disorder: is there an interaction?
    Hong SB; Kim JW; Cho SC; Shin MS; Kim BN; Yoo HJ
    J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):343-52. PubMed ID: 23083021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
    Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH
    Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: a pharmacogenetic study.
    Hamarman S; Fossella J; Ulger C; Brimacombe M; Dermody J
    J Child Adolesc Psychopharmacol; 2004; 14(4):564-74. PubMed ID: 15662148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).
    Kooij JS; Boonstra AM; Vermeulen SH; Heister AG; Burger H; Buitelaar JK; Franke B
    Am J Med Genet B Neuropsychiatr Genet; 2008 Mar; 147B(2):201-8. PubMed ID: 17955457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine transporter genotype influences the physiological response to medication in ADHD.
    Gilbert DL; Wang Z; Sallee FR; Ridel KR; Merhar S; Zhang J; Lipps TD; White C; Badreldin N; Wassermann EM
    Brain; 2006 Aug; 129(Pt 8):2038-46. PubMed ID: 16760197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular imaging genetics of methylphenidate response in ADHD and substance use comorbidity.
    Szobot CM; Roman T; Hutz MH; Genro JP; Shih MC; Hoexter MQ; Júnior N; Pechansky F; Bressan RA; Rohde LA
    Synapse; 2011 Feb; 65(2):154-9. PubMed ID: 20593420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate.
    Cheon KA; Ryu YH; Kim JW; Cho DY
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):95-101. PubMed ID: 15572278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of 4-repeat allele of the dopamine D4 receptor gene exon III polymorphism and response to methylphenidate treatment in Korean ADHD children.
    Cheon KA; Kim BN; Cho SC
    Neuropsychopharmacology; 2007 Jun; 32(6):1377-83. PubMed ID: 17077808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children.
    Kereszturi E; Tarnok Z; Bognar E; Lakatos K; Farkas L; Gadoros J; Sasvari-Szekely M; Nemoda Z
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1431-5. PubMed ID: 18214865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of auto-antibodies to DAT in the serum: interactions with DAT genotype and psycho-stimulant therapy for ADHD.
    Giana G; Romano E; Porfirio MC; D'Ambrosio R; Giovinazzo S; Troianiello M; Barlocci E; Travaglini D; Granstrem O; Pascale E; Tarani L; Curatolo P; Laviola G; Adriani W
    J Neuroimmunol; 2015 Jan; 278():212-22. PubMed ID: 25468771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
    Quinn D; Wigal S; Swanson J; Hirsch S; Ottolini Y; Dariani M; Roffman M; Zeldis J; Cooper T
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1422-9. PubMed ID: 15502602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
    Crunelle CL; van den Brink W; Veltman DJ; van Emmerik-van Oortmerssen K; Dom G; Schoevers RA; Booij J
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1714-23. PubMed ID: 23731497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
    Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
    Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional brain perfusion before and after treatment with methylphenidate may be associated with the G1287A polymorphism of the norepinephrine transporter gene in children with attention-deficit/hyperactivity disorder.
    Park MH; Kim JW; Yang YH; Hong SB; Park S; Kang H; Kim BN; Shin MS; Yoo HJ; Cho SC
    Neurosci Lett; 2012 Apr; 514(2):159-63. PubMed ID: 22405810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.